Progressive disease in chronic lymphocytic leukemia is correlated with the DNA methylation index

Leukemia Research

Volumn 31, Issue 6, 2007, Pages 773-777

  Yu, Margaret K ^a,b   Bergonia, Hector ^a   Szabo, Aniko ^b   Phillips, John D ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Chronic lymphocytic leukemia; DNA methylation; Hypermethylation; Hypomethylation; Progressive disease

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; CHROMOSOME ABERRATION; CHRONIC LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA METHYLATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS;

EID: 34249827572     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.07.007     Document Type: Article

References (22)

1. Hamblin T.J., Davis Z., Gardiner A., Oscier D.G., and Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukaemia. Blood 94 (1999) 1848
2. Dohner H., Stilgenbauer S., Benner A., Leupolt E., Krober A., Bullinger L., et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343 (2000) 1910
3. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L., et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94 (1999) 1840
4. Wiestner A., Rosenwald A., Barry T.S., Wright G., Davis R.E., Henrickson S.E., et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101 (2003) 4944
5. Chen Z., Aston E., and Yu M.K. Loss of Zap-70 and low molecular weight phosphotyrosine phosphatase occurs after therapy in a patient with B-chronic lymphocytic leukemia. Leukemia 19 (2005) 1503
6. Hamblin T.J., Orchard J.A., Ibbotson R.E., Davis Z., Thomas P.W., Stevenson F.K., et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 99 (2002) 1023
7. Wahlfors J., Hiltunen H., Heinonen K., Hamalainen E., Alhonen L., and Janne J. Genomic hypomethylation in human chronic lymphocytic leukemia. Blood 80 (1992) 2074
8. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 21 (2002) 5400
9. Daskalakis M., Nguyen T.T., Nguyen C., Guldberg P., Kohler G., Wijermans P., et al. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment. Blood 100 (2002) 2957
10. Graff J.R., Herman J.G., Myohanen S., Baylin S.B., and Vertino P.M. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem 272 (1997) 22322
11. Lyko F., and Brown R. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst 97 (2005) 1498
12. Fulop Z., Csernus B., Timar B., Szepesi A., and Matolcsy A. Microsatellite instability and hMLH1 promoter hypermethylation in Richter's transformation of chronic lymphocytic leukemia. Leukemia 17 (2003) 411
13. Pinyol M., Cobo F., Bea S., Jares P., Nayach I., Fernandez P.L., et al. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 91 (1998) 2977
14. Paredes J., Albergaria A., Oliveira J.T., Jeronimo C., Milanezi F., and Schmitt F.C. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin Cancer Res 11 (2005) 5869
15. Goorha S., Glenn M.J., Drozd-Borysiuk E., and Chen Z. A set of commercially available fluorescent in-situ hybridization probes efficiently detects cytogenetic abnormalities in patients with chronic lymphocytic leukemia. Genet Med 6 (2004) 48
16. Pinheiro J, Bates D, DebRoy S, Sarkar D. Linear and nonlinear mixed effects models. In R package version 3.1-57 edition; 2005.
17. Team RDC. A language and environment for statistical computing. In: Foundation for Statistical Computing; 2005.
18. Fuke C., Shimabukuro M., Petronis A., Sugimoto J., Oda T., Miura K., et al. Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann Hum Genet 68 (2004) 196
19. Watson R.E., Curtin G.M., Doolittle D.J., and Goodman J.I. Progressive alterations in global and GC-rich DNA methylation during tumorigenesis. Toxicol Sci 75 (2003) 289
20. van Engeland M., Weijenberg M.P., Roemen G.M., Brink M., de Bruine A.P., Goldbohm R.A., et al. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res 63 (2003) 3133
21. Poirier L.A., Wise C.K., Delongchamp R.R., and Sinha R. Blood determinations of S-adenosylmethionine, S-adenosylhomocysteine, and homocysteine: correlations with diet. Cancer Epidemiol Biomarkers Prev 10 (2001) 649
22. Choi S.W., Stickel F., Baik H.W., Kim Y.I., Seitz H.K., and Mason J.B. Chronic alcohol consumption induces genomic but not p53-specific DNA hypomethylation in rat colon. J Nutr 129 (1999) 1945